Supplementary Materials and Methods
Complex pull-down
The complex was expressed in Sf9 cells with LiRad51-3-GST-His, LiRad51-4-V5 and LiRad51-6-HA baculoviruses for 72h. GST pull-down was performed as described in (51) and the proteins were visualized by Western blotting using the indicated antibodies (anti-Histidine (Clontech), anti-V5 (Fisher), anti-HA 16B12 (Covance)).
Immunoprecipitation using anti-HA antibody was performed on Sf9 cells extracts infected with LiRad51-3-Myc, LiRad51-6-HA and LiRad51-4-V5 baculoviruses for 72h. The cell pellet was resuspended in 20 ml of IP150 buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.5% NP40) containing protease inhibitors PMSF (1 mM), aprotinin (0,019 UIT/mL) and leupeptin (1 µg/mL). The lysate was sonicated 3 times for 30 seconds with a Branson sonifier at 30 % burst and centrifuged 20 min, 13 000 rpm at 4°C. 40 µg of anti-HA 16B12 (Covance) were added to soluble extract (140 mg) and incubated for 2 hours at 4°C. A volume of 100 µL of protein A/G sepharose beads (Pierce) was added followed by an 1 hour period incubation at 4°C. Beads were washed two times with IP150 buffer and proteins were eluted with 50 µg of peptide HA in PBS overnight. Proteins were visualized by Western blotting using the indicated antibodies (anti-Myc Cell Signaling), anti-V5 (Fisher), anti-HA 16B12 (Covance)). (E) PCR analysis of five different populations after integration of the HYG and NEO cassettes with or without drug selection for the complemented plasmid by using specific primers to amplify puromycin gene. Amplification of the chromosomal GAPDH gene was used as loading control.
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